Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Comments
Loading...
Alkermes Analyst Ratings and Price Targets | NASDAQ:ALKS | Benzinga
Alkermes PLC has a consensus price target of $36.8 based on the ratings of 17 analysts. The high is $50 issued by Jefferies on April 9, 2024. The low is $26 issued by JP Morgan on October 25, 2024. The 3 most-recent analyst ratings were released by RBC Capital, Goldman Sachs, and HC Wainwright & Co. on March 13, 2025, February 14, 2025, and February 13, 2025, respectively. With an average price target of $39.33 between RBC Capital, Goldman Sachs, and HC Wainwright & Co., there's an implied 13.32% upside for Alkermes PLC from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
RBC Capital
Goldman Sachs
HC Wainwright & Co.
Deutsche Bank
Mizuho
1calculated from analyst ratings
Analyst Ratings for Alkermes
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 03/13/2025 | Buy Now | 15.24% | RBC Capital | Leonid Timashev45% | → $40 | Initiates | → Sector Perform | Get Alert |
| 03/04/2025 | Buy Now | — | UBS | Ashwani Verma48% | — | Upgrade | Sell → Neutral | Get Alert |
| 02/14/2025 | Buy Now | -7.81% | Goldman Sachs | Chris Shibutani54% | $30 → $32 | Maintains | Buy | Get Alert |
| 02/13/2025 | Buy Now | 32.53% | HC Wainwright & Co. | Douglas Tsao53% | $46 → $46 | Reiterates | Neutral → Neutral | Get Alert |
| 02/11/2025 | Buy Now | 15.24% | Deutsche Bank | David Hoang42% | → $40 | Initiates | → Buy | Get Alert |
| 11/13/2024 | Buy Now | 15.24% | Mizuho | Uy Ear63% | $35 → $40 | Maintains | Outperform | Get Alert |
| 11/05/2024 | Buy Now | 3.72% | Stifel | Paul Matteis44% | $25 → $36 | Upgrade | Hold → Buy | Get Alert |
| 10/25/2024 | Buy Now | -13.57% | Goldman Sachs | Chris Shibutani54% | $32 → $30 | Maintains | Buy | Get Alert |
| 10/25/2024 | Buy Now | 23.88% | Cantor Fitzgerald | Charles Duncan72% | $48 → $43 | Maintains | Overweight | Get Alert |
| 10/25/2024 | Buy Now | -25.09% | JP Morgan | Jessica Fye68% | $32 → $26 | Maintains | Neutral | Get Alert |
| 10/25/2024 | Buy Now | 6.6% | Piper Sandler | David Amsellem69% | $38 → $37 | Reiterates | Overweight → Overweight | Get Alert |
| 10/25/2024 | Buy Now | 6.6% | HC Wainwright & Co. | Douglas Tsao53% | $37 → $37 | Reiterates | Neutral → Neutral | Get Alert |
| 10/14/2024 | Buy Now | 6.6% | HC Wainwright & Co. | Douglas Tsao53% | $37 → $37 | Reiterates | Neutral → Neutral | Get Alert |
| 10/10/2024 | Buy Now | 38.29% | Cantor Fitzgerald | Charles Duncan72% | $48 → $48 | Reiterates | Overweight → Overweight | Get Alert |
| 09/16/2024 | Buy Now | 38.29% | Cantor Fitzgerald | Charles Duncan72% | $48 → $48 | Reiterates | Overweight → Overweight | Get Alert |
| 07/25/2024 | Buy Now | 38.29% | Cantor Fitzgerald | Charles Duncan72% | $48 → $48 | Reiterates | Overweight → Overweight | Get Alert |
| 07/25/2024 | Buy Now | -7.81% | JP Morgan | Jessica Fye68% | $31 → $32 | Maintains | Neutral | Get Alert |
| 07/25/2024 | Buy Now | 9.48% | Baird | Joel Beatty69% | $37 → $38 | Maintains | Outperform | Get Alert |
| 07/25/2024 | Buy Now | 6.6% | HC Wainwright & Co. | Douglas Tsao53% | $35 → $37 | Maintains | Neutral | Get Alert |
| 07/15/2024 | Buy Now | -10.69% | JP Morgan | Jessica Fye68% | $32 → $31 | Maintains | Neutral | Get Alert |
| 06/17/2024 | Buy Now | -2.05% | TD Cowen | Joseph Thome34% | → $34 | Initiates | → Buy | Get Alert |
| 06/04/2024 | Buy Now | 0.84% | HC Wainwright & Co. | Douglas Tsao53% | $35 → $35 | Reiterates | Neutral → Neutral | Get Alert |
| 05/23/2024 | Buy Now | 38.29% | Cantor Fitzgerald | Charles Duncan72% | $43 → $48 | Maintains | Overweight | Get Alert |
| 05/02/2024 | Buy Now | 0.84% | HC Wainwright & Co. | Douglas Tsao53% | $35 → $35 | Reiterates | Neutral → Neutral | Get Alert |
| 04/19/2024 | Buy Now | 0.84% | HC Wainwright & Co. | Douglas Tsao53% | $35 → $35 | Reiterates | Neutral → Neutral | Get Alert |
| 04/09/2024 | Buy Now | 44.05% | Jefferies | Akash Tewari45% | $42 → $50 | Maintains | Buy | Get Alert |
| 04/01/2024 | Buy Now | 12.36% | Piper Sandler | David Amsellem69% | $39 → $39 | Reiterates | Overweight → Overweight | Get Alert |
| 03/19/2024 | Buy Now | 6.6% | Baird | Joel Beatty69% | → $37 | Initiates | → Outperform | Get Alert |
| 02/20/2024 | Buy Now | -27.97% | UBS | Ashwani Verma48% | $25 → $25 | Downgrade | Neutral → Sell | Get Alert |
| 02/16/2024 | Buy Now | 12.36% | Piper Sandler | David Amsellem69% | $35 → $39 | Maintains | Overweight | Get Alert |
| 01/02/2024 | Buy Now | -16.45% | B of A Securities | Jason Gerberry64% | $27 → $29 | Maintains | Neutral | Get Alert |
| 11/20/2023 | Buy Now | -4.93% | JP Morgan | Jessica Fye68% | → $33 | Reinstates | → Neutral | Get Alert |
| 10/27/2023 | Buy Now | 0.84% | Piper Sandler | David Amsellem69% | $37 → $35 | Maintains | Overweight | Get Alert |
| 10/26/2023 | Buy Now | 0.84% | Mizuho | Uy Ear63% | $37 → $35 | Maintains | Buy | Get Alert |
| 10/24/2023 | Buy Now | — | Evercore ISI Group | Umer Raffat43% | — | Upgrade | In-Line → Outperform | Get Alert |
| 10/17/2023 | Buy Now | -10.69% | UBS | Ashwani Verma48% | → $31 | Initiates | → Neutral | Get Alert |
| 07/27/2023 | Buy Now | -2.05% | HC Wainwright & Co. | Douglas Tsao53% | → $34 | Reiterates | Neutral → Neutral | Get Alert |
| 06/07/2023 | Buy Now | 6.6% | Piper Sandler | David Amsellem69% | $35 → $37 | Maintains | Overweight | Get Alert |
| 06/06/2023 | Buy Now | -4.93% | Stifel | Paul Matteis44% | $31 → $33 | Maintains | Hold | Get Alert |
| 04/27/2023 | Buy Now | 3.72% | Mizuho | Uy Ear63% | $37 → $36 | Maintains | Buy | Get Alert |
| 04/27/2023 | Buy Now | -2.05% | HC Wainwright & Co. | Douglas Tsao53% | $32 → $34 | Maintains | Neutral | Get Alert |
| 04/25/2023 | Buy Now | -10.69% | JP Morgan | Jessica Fye68% | $29 → $31 | Maintains | Neutral | Get Alert |
| 04/11/2023 | Buy Now | 6.6% | Mizuho | Uy Ear63% | $36 → $37 | Maintains | Buy | Get Alert |
| 02/17/2023 | Buy Now | -7.81% | HC Wainwright & Co. | Douglas Tsao53% | → $32 | Reiterates | → Neutral | Get Alert |
| 12/06/2022 | Buy Now | -16.45% | JP Morgan | Jessica Fye68% | $33 → $29 | Maintains | Neutral | Get Alert |
| 11/22/2022 | Buy Now | 3.72% | Mizuho | Uy Ear63% | $34 → $36 | Maintains | Buy | Get Alert |
| 11/03/2022 | Buy Now | -13.57% | Piper Sandler | David Amsellem69% | $26 → $30 | Upgrade | Neutral → Overweight | Get Alert |
| 10/14/2022 | Buy Now | -27.97% | B of A Securities | Jason Gerberry64% | $27 → $25 | Upgrade | Underperform → Neutral | Get Alert |
| 08/16/2022 | Buy Now | -25.09% | Piper Sandler | David Amsellem69% | → $26 | Initiates | → Neutral | Get Alert |
| 07/28/2022 | Buy Now | -2.05% | Mizuho | Vamil Divan76% | $36 → $34 | Maintains | Buy | Get Alert |
| 04/28/2022 | Buy Now | -22.21% | SVB Leerink | Marc Goodman74% | $24 → $27 | Maintains | Market Perform | Get Alert |
| 04/28/2022 | Buy Now | -7.81% | HC Wainwright & Co. | Douglas Tsao53% | $30 → $32 | Maintains | Neutral | Get Alert |
| 04/21/2022 | Buy Now | -27.97% | SVB Leerink | Marc Goodman74% | $24 → $25 | Maintains | Market Perform | Get Alert |
| 04/20/2022 | Buy Now | 0.84% | Goldman Sachs | Chris Shibutani54% | → $35 | Initiates | → Buy | Get Alert |
FAQ
What is the target price for Alkermes (ALKS) stock?
The latest price target for Alkermes (NASDAQ:ALKS) was reported by RBC Capital on March 13, 2025. The analyst firm set a price target for $40.00 expecting ALKS to rise to within 12 months (a possible 15.24% upside). 27 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Alkermes (ALKS)?
The latest analyst rating for Alkermes (NASDAQ:ALKS) was provided by RBC Capital, and Alkermes initiated their sector perform rating.
When was the last upgrade for Alkermes (ALKS)?
The last upgrade for Alkermes PLC happened on March 4, 2025 when UBS raised their price target to N/A. UBS previously had a sell for Alkermes PLC.
When was the last downgrade for Alkermes (ALKS)?
The last downgrade for Alkermes PLC happened on February 20, 2024 when UBS changed their price target from $25 to $25 for Alkermes PLC.
When is the next analyst rating going to be posted or updated for Alkermes (ALKS)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Alkermes, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Alkermes was filed on March 13, 2025 so you should expect the next rating to be made available sometime around March 13, 2026.
Is the Analyst Rating Alkermes (ALKS) correct?
While ratings are subjective and will change, the latest Alkermes (ALKS) rating was a initiated with a price target of $0.00 to $40.00. The current price Alkermes (ALKS) is trading at is $34.71, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.